What is the current price and market cap of AIDX.TO stock?

AIDX.TO stock trades pre-market at **C$0.67** with a market cap of **C$186.53M**. Volume is elevated at **778,693** shares versus an average of **502,159**, indicating higher intraday interest.

What does the Meyka AI forecast say for AIDX.TO stock?

Meyka AI's forecast model projects monthly **C$0.54**, quarterly **C$0.64**, and yearly **C$0.47** for AIDX.TO stock. These are model projections and imply a 12-month downside of **-29.32%** from the current price.

What are the main risks to AIDX.TO stock investors?

Main risks include negative operating cash flow, low current ratio **0.85**, continued EPS losses, and sector rotation away from small-cap AI healthcare names. Earnings on **26 Mar 2026** could increase volatility.

Does Meyka AI give a buy or sell rating for AIDX.TO stock?

Meyka AI rates AIDX.TO **53.98 (C+) — HOLD**. This grade incorporates benchmark and sector comparisons, financial growth, key metrics, and consensus data. It is informational and not investment advice.

CA Stocks

AIDX.TO Healwell AI Inc. (TSX) pre-market 17 Feb 2026: C$0.67, model flags downside

ByDanny Kontos February 17, 2026February 17, 2026

AIDX.TO stock opens pre-market on 17 Feb 2026 at C$0.67, down 1.47% from the prior close. Healwell AI Inc. (AIDX.TO) trades on the TSX with a market cap of C$186.53M and a 50-day average price of C$0.85. Investors in AI healthcare names should weigh weak profitability metrics against product partnerships and sector momentum. This note frames the near-term technical picture, fundamentals, Meyka AI forecast, and realistic price targets for AIDX.TO stock.